Ivabradine for the treatment of cardiovascular diseases

Tomomi Ide, Kisho Ohtani, Taiki Higo, Makoto Tanaka, Yasushi Kawasaki, Hiroyuki Tsutsui

研究成果: ジャーナルへの寄稿評論記事

3 引用 (Scopus)

抄録

Higher heart rate (HR) is independently related to worse outcomes in various cardiac diseases, including hypertension, coronary artery disease, and heart failure (HF). HR is determined by the pacemaker activity of cells within the sinoatrial node. The hyperpolarization- activated cyclic nucleotide-gated (HCN) 4 channel, one of 4 HCN isoforms, generates the If current and plays an important role in the regulation of pacemaker activity in the sinoatrial node. Ivabradine is a novel and only available HCN inhibitor, which can reduce HR and has been approved for stable angina and chronic HF in many countries other than Japan. In this review, we summarize the current knowledge of the HCN4 channel and ivabradine, including the function of HCN4 in cardiac pacemaking, the mechanism of action of If inhibition by ivabradine, and the pharmacological and clinical effects of ivabradine in cardiac diseases as HF, coronary artery disease, and atrial fibrillation.

元の言語英語
ページ(範囲)252-260
ページ数9
ジャーナルCirculation Journal
83
発行部数2
DOI
出版物ステータス出版済み - 2 2019

Fingerprint

ivabradine
Cardiovascular Diseases
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
Sinoatrial Node
Heart Failure
Heart Rate
Cyclic Nucleotides
Coronary Artery Disease
Heart Diseases
Stable Angina
Therapeutics
Atrial Fibrillation
Japan
Protein Isoforms
Pharmacology
Hypertension

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

これを引用

Ivabradine for the treatment of cardiovascular diseases. / Ide, Tomomi; Ohtani, Kisho; Higo, Taiki; Tanaka, Makoto; Kawasaki, Yasushi; Tsutsui, Hiroyuki.

:: Circulation Journal, 巻 83, 番号 2, 02.2019, p. 252-260.

研究成果: ジャーナルへの寄稿評論記事

Ide, Tomomi ; Ohtani, Kisho ; Higo, Taiki ; Tanaka, Makoto ; Kawasaki, Yasushi ; Tsutsui, Hiroyuki. / Ivabradine for the treatment of cardiovascular diseases. :: Circulation Journal. 2019 ; 巻 83, 番号 2. pp. 252-260.
@article{6bfe4931f39442c3aab147a341a7727b,
title = "Ivabradine for the treatment of cardiovascular diseases",
abstract = "Higher heart rate (HR) is independently related to worse outcomes in various cardiac diseases, including hypertension, coronary artery disease, and heart failure (HF). HR is determined by the pacemaker activity of cells within the sinoatrial node. The hyperpolarization- activated cyclic nucleotide-gated (HCN) 4 channel, one of 4 HCN isoforms, generates the If current and plays an important role in the regulation of pacemaker activity in the sinoatrial node. Ivabradine is a novel and only available HCN inhibitor, which can reduce HR and has been approved for stable angina and chronic HF in many countries other than Japan. In this review, we summarize the current knowledge of the HCN4 channel and ivabradine, including the function of HCN4 in cardiac pacemaking, the mechanism of action of If inhibition by ivabradine, and the pharmacological and clinical effects of ivabradine in cardiac diseases as HF, coronary artery disease, and atrial fibrillation.",
author = "Tomomi Ide and Kisho Ohtani and Taiki Higo and Makoto Tanaka and Yasushi Kawasaki and Hiroyuki Tsutsui",
year = "2019",
month = "2",
doi = "10.1253/circj.CJ-18-1184",
language = "English",
volume = "83",
pages = "252--260",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "2",

}

TY - JOUR

T1 - Ivabradine for the treatment of cardiovascular diseases

AU - Ide, Tomomi

AU - Ohtani, Kisho

AU - Higo, Taiki

AU - Tanaka, Makoto

AU - Kawasaki, Yasushi

AU - Tsutsui, Hiroyuki

PY - 2019/2

Y1 - 2019/2

N2 - Higher heart rate (HR) is independently related to worse outcomes in various cardiac diseases, including hypertension, coronary artery disease, and heart failure (HF). HR is determined by the pacemaker activity of cells within the sinoatrial node. The hyperpolarization- activated cyclic nucleotide-gated (HCN) 4 channel, one of 4 HCN isoforms, generates the If current and plays an important role in the regulation of pacemaker activity in the sinoatrial node. Ivabradine is a novel and only available HCN inhibitor, which can reduce HR and has been approved for stable angina and chronic HF in many countries other than Japan. In this review, we summarize the current knowledge of the HCN4 channel and ivabradine, including the function of HCN4 in cardiac pacemaking, the mechanism of action of If inhibition by ivabradine, and the pharmacological and clinical effects of ivabradine in cardiac diseases as HF, coronary artery disease, and atrial fibrillation.

AB - Higher heart rate (HR) is independently related to worse outcomes in various cardiac diseases, including hypertension, coronary artery disease, and heart failure (HF). HR is determined by the pacemaker activity of cells within the sinoatrial node. The hyperpolarization- activated cyclic nucleotide-gated (HCN) 4 channel, one of 4 HCN isoforms, generates the If current and plays an important role in the regulation of pacemaker activity in the sinoatrial node. Ivabradine is a novel and only available HCN inhibitor, which can reduce HR and has been approved for stable angina and chronic HF in many countries other than Japan. In this review, we summarize the current knowledge of the HCN4 channel and ivabradine, including the function of HCN4 in cardiac pacemaking, the mechanism of action of If inhibition by ivabradine, and the pharmacological and clinical effects of ivabradine in cardiac diseases as HF, coronary artery disease, and atrial fibrillation.

UR - http://www.scopus.com/inward/record.url?scp=85060642797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060642797&partnerID=8YFLogxK

U2 - 10.1253/circj.CJ-18-1184

DO - 10.1253/circj.CJ-18-1184

M3 - Review article

C2 - 30606942

AN - SCOPUS:85060642797

VL - 83

SP - 252

EP - 260

JO - Circulation Journal

JF - Circulation Journal

SN - 1346-9843

IS - 2

ER -